Reported 6 months ago
The article discusses the upcoming American Society of Clinical Oncology (ASCO) annual meeting in Chicago, focusing on cutting-edge cancer technology and treatments in the biotech sector. Jefferies Biotechnology Managing Director Michael Yee provides insight on the conference, mentioning the impact of AI in oncology and highlighting companies like Schrodinger and Recursion. Yee also discusses advancements in cancer treatment, including immunotherapy and new modalities like CAR-T and cancer vaccines. Specific companies like Maris are mentioned for their promising developments in cancer treatment, with potential for phase three trials and M&A activity. Overall, the article emphasizes the ongoing advancements and potential in the field of oncology and biotechnology.
Source: YAHOO